關鍵數據
0.266今開
0.264最高
112.55K成交量
虧損本益比TTM
虧損本益比動
--股利TTM
0.97%換手率
0.263昨收
0.243最低
27.65K成交額
虧損本益比靜
-0.09市淨率
0.00%股息率 TTM
-281.72%ROA
3.26052週最高
0.03量比
-26.97M淨利潤
11.59M總股本
-4.2173每股盈餘TTM
1.06Beta
-5396.85%ROE
0.24352週最低
7.99%振幅
100.00%毛利率
2.82M總市值
-9.51回報/風險
123.23%風險率

即將為您帶來更多新聞,敬請期待。 。 。
VolitionRX Ltd評分
-0.06與上次評分對比預測7.60
財務診斷5.70
技術分析6.85
公司估值9.31
機構認同度3.00
風險評估1.54
分析師評級
買入評級
13.622目標均價
+5139.23%漲幅空間
VolitionRX Ltd 最新財報電話會記錄
VolitionRx (VNRX) 2026 年第二季法說會:隨著 Nu.Q 研發管線推進成本下滑
VolitionRx 2026 年第二季營收維持在 40 萬美元,費用則下降 32%。VNRX 強調了 Nu.Q NETs、肺癌給付以及貓科領域的里程碑。
財務指標
貨幣: USD

由於公司未披露,未能獲取相關數據
貨幣: USD

由於公司未披露,未能獲取相關數據
VolitionRX Ltd 簡介
VolitionRx Limited is a multi-national company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer, and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.
行業生物技術與醫療研究
公司代碼VNRX
員工數量85
國家United States of America
持股情況
| 持股股東 | 佔比 |
|---|
| Cotterford Co., Ltd. | 7.42% |
|---|
| Lagoda Investment Management, L.P. | 7.09% |
|---|
| The Lind Partners, LLC | 2.76% |
|---|
| Innes (Guy Archibald) | 2.43% |
|---|
| 股東類型 | 佔比 |
|---|
| Investment Advisor | 11.58% |
|---|
| Corporation | 8.04% |
|---|
| Individual Investor | 7.07% |
|---|
| Investment Advisor/Hedge Fund | 1.07% |
|---|
常見問題
VolitionRX Ltd(VNRX)的當前股價是多少?
VolitionRX Ltd(VNRX)的當前股價是 0.26。
VolitionRX Ltd 的股票代碼是什麼?
VolitionRX Ltd的股票代碼是VNRX。
VolitionRX Ltd股票的52週最高點是多少?
VolitionRX Ltd股票的52週最高點是3.26。
VolitionRX Ltd股票的52週最低點是多少?
VolitionRX Ltd股票的52週最低點是2.66。
現在VolitionRX Ltd(VNRX)的股票是買入、持有還是賣出?
根據分析師評級,VolitionRX Ltd(VNRX)的總體評級為買入,目標價格為13.62。
VolitionRX Ltd(VNRX)股票的每股收益(EPS TTM)是多少
VolitionRX Ltd(VNRX)股票的每股收益(EPS TTM)是-4.22。